arrow
J

Jia-Ren Lin

Harvard University
H指数:39
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-cell and spatial mapping reveals GCLC+ mesenchymal tumor cells linked with favorable outcomes in TNBC

单细胞和空间图谱揭示GCLC+间充质肿瘤细胞与TNBC良好预后的关联

2026-10-230
OAAI
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation

RNF43 p.G659fs通过PI3K/AKT/mTOR信号通路和HLA-E上调导致MSI-high结直肠癌中自然杀伤细胞功能障碍

2026-09-230
OA
Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial

奥拉帕尼与尼沃鲁单抗联合治疗微卫星稳定型结直肠癌:一项1/2期临床试验

2026-07-230
OA
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy

活细胞Pick-Seq (LiP-Seq):CART19疗法后检测超罕见套细胞淋巴瘤持续性细胞

2026-03-230
OAAI
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity
2026-01-210
PRE
Immune profiling in a living human recipient of a gene-edited pig kidney

在基因编辑的猪肾的活人类受体中进行免疫分析

2026-01-080
OAAI
Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging

基质辅助激光解吸电离质谱成像技术对元素的时空分布表征

2025-11-010
PRE
Integrated multiomic profiling identifies genomic and immune microenvironmental changes as candidate resistance mechanisms to PD-1 blockade in high-grade meningiomas

整合多组学分析鉴定出基因组改变和免疫微环境变化为高级别脑膜瘤对PD-1阻断治疗的候选耐药机制

2025-11-010
OAAI
Skin immune-mesenchymal interplay within tertiarylymphoid structures promotes autoimmunepathogenesis in hidradenitis suppurativa

HS患者三级淋巴样结构中皮肤免疫-间质细胞间的相互作用促进了自身免疫病的发生发展。

IMMUNITY
IF26.3
2024-12-013
PRE
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

AKT和EZH2抑制剂通过劫持退化机制杀死TNBCs

Nature
IF48.5
2024-10-090
OAAI
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
2024-08-120
OAAI
Multimodal spatial profiling reveals the emergence of an immune suppressive microenvironment at the initial stages of high-grade serous ovarian cancer development
2024-04-050
PRE
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer
2024-01-022
OA
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
2023-07-142
OAAI